Prestige Consumer Healthcare (PBH) Operating Income (QoQ) (2010 - 2025)
Prestige Consumer Healthcare (PBH) Operating Income (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.55 Bn | 87.69 Bn | - |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.45 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.47 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.38 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.54% |
| Sep 30, 2025 | 11.03% |
| Jun 30, 2025 | -18.85% |
| Mar 31, 2025 | -3.84% |
| Dec 31, 2024 | 9.04% |
| Sep 30, 2024 | 17.06% |
| Jun 30, 2024 | -12.30% |
| Mar 31, 2024 | -5.39% |
| Dec 31, 2023 | -1.61% |
| Sep 30, 2023 | 3.59% |
| Jun 30, 2023 | 130.32% |
| Mar 31, 2023 | -422.30% |
| Dec 31, 2022 | 3.32% |
| Sep 30, 2022 | -3.02% |
| Jun 30, 2022 | 12.38% |
| Mar 31, 2022 | -6.26% |
| Dec 31, 2021 | 5.14% |
| Sep 30, 2021 | -14.00% |
| Jun 30, 2021 | 28.76% |
| Mar 31, 2021 | -3.41% |